Therapeutic Potential of Antimicrobial Peptide PN5 against Multidrug-Resistant E. coli and Anti-Inflammatory Activity

Da Dam Kang1, Jonggwan Park2, Yoonkyung Park1,3

  • 1Department of Biomedical Science, Chosun Universitygrid.254187.d, Gwangju, South Korea.

Microbiology Spectrum
|September 21, 2022
PubMed

Insights

A novel antimicrobial peptide, PN5 from pine needles, shows potent antibacterial and anti-inflammatory effects against drug-resistant bacteria. It effectively treats septic shock in mice without inducing further resistance, offering a promising alternative to conventional antibiotics.

Area of Science:

  • Biochemistry
  • Microbiology
  • Immunology

Background:

  • Antibiotic-resistant bacteria pose a significant global health threat.
  • Antimicrobial peptides (AMPs) are being explored as alternatives to conventional antibiotics.
  • There is a critical need for novel therapeutic agents to combat multidrug-resistant infections.

Purpose of the Study:

  • To investigate the antimicrobial and anti-inflammatory properties of PN5, a peptide derived from Pinus densiflora (pine needle).
  • To elucidate the mechanism of action of PN5 against Gram-negative and Gram-positive bacteria.
  • To evaluate the therapeutic potential of PN5 in a mouse model of septic shock.

Main Methods:

  • PN5 was isolated and its antimicrobial activity was assessed against various bacterial strains.
  • Cytotoxicity assays were performed to determine the safety profile of PN5.
  • Mechanisms of action, including membrane permeabilization and resistance induction, were investigated.
  • Anti-inflammatory effects were evaluated in vitro using macrophages and in vivo using a mouse septic shock model.

Main Results:

  • PN5 demonstrated significant antimicrobial activity against multidrug-resistant bacteria without exhibiting cytotoxic effects.
  • PN5 acts by permeabilizing bacterial membranes and does not induce bacterial resistance.
  • PN5 suppressed pro-inflammatory cytokine production and demonstrated therapeutic efficacy in a mouse model of LPS-induced septic shock.
  • PN5 showed stability against proteolytic degradation by elastase.

Conclusions:

  • PN5 possesses potent antimicrobial and anti-inflammatory activities.
  • PN5 is a promising candidate for the development of new therapeutic agents against infections caused by antibiotic-resistant bacteria.
  • PN5 may serve as a valuable treatment for conditions like septic shock, offering a novel approach to combatting antimicrobial resistance.